{"name":"Topas Therapeutics GmbH","slug":"topas-therapeutics-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxPMmJLdUNWZ21ubUFwUnBDRTZhVGIwU0tfMlJiME9hTE1NSmZTMXFyRkliUXpqN2FzWDZGT1JQcTAwajJja3VVZGxNZFYtclpjUjhyZmpNd0pNeWpOa2FHNDJWZm9yRGRReVRrTU03akJWdlMyMG9YX0w0ZFppYmFfVDFYZU8tNmNXaTBPbGx6RDZHS1hDWlBZMzNzQnpVMnB3ZEVoOHdqdTh3ZmthOS04cnBmM1JWazBCTnkyUy1iQ0F1U29iWnZVSHRIR1BoYnpjUVdkZHZIbFNiY1pORWhRWWl1Z2V2eFlmOE94QnRkQ3RLM0hzdVBjcTVVNGd4ODZFdnE4NENLcEdKcDI5UVM0UXZIdTdCNkVBVEotNURyRFdLNkx2WnZpTVpuYnJod3lfenNhNVk1bXEwX3oxVDVjaV81WVBLc1R0Q1hmRw?oc=5","date":"2026-01-29","type":"regulatory","source":"Barchart.com","summary":"Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical, Calypso Biotech - Barch","headline":"Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBWcGpYRk4zS2E3Qk0xZTRkeW1odXpMWFBrUklhMVdfQ01GV0Vkai03N0FRWlJ0SzN5LUNSVndoY1Z4cWpGbnRGWkltMHFDbEUwcXpEankyb3pEMmtoOTFOSzlfdHZhRWNNb1BRLXFyd3U4bmlqMlRZS0FoNDhUZw?oc=5","date":"2024-12-17","type":"pipeline","source":"Fortune Business Insights","summary":"Celiac Disease Drug Market Size, Share, Trends & Growth, 2034 - Fortune Business Insights","headline":"Celiac Disease Drug Market Size, Share, Trends & Growth, 2034","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-02-15","type":"pipeline","source":"boerse.de","summary":"DGAP-News: Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer - boerse.de - boerse.de","headline":"DGAP-News: Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer - boerse.de","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPcEpDRVF4VUJVSnBDTF9PTGM4dXFmd0R3aTdGdkdlZy0tTFBsNE1heEVpU2JYVTVPMTZuUmFBemlWX29rNjNMSnp0cjFGYjFpVVN0QmRDVEZVbUFCU3dvOTl2a0QtUDcwZnlEend4S0pRLWRxSjZHbkpTQUVfdlZIZHI2ZjA0TUdHZm9NS1JVV29scS1xLTRMQ2EzbnlLZUdycTlxRk1zMVd3SElNakJSbUZWQ1RvanljLXk3QTlJUHUxNUxIWmxSMTc2NzRQNm5sSTljOFFrVFRiR3FXRHdxS2pFM1pXRjdQQUxZdm1lbUR4cVJpRWt3b3ZjNGE0N3BNUi1WaUZuODZmNk52UkM4cG1qRkJXNW1OQnZIN1c1ZFJiR25EQ2VxMFZmTUxBOUgzLXV0MDIwTjNucWc?oc=5","date":"2020-10-01","type":"pipeline","source":"prnewswire.com","summary":"Dutch Vico Therapeutics strengthens leadership team with the appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director - prnewswire.com","headline":"Dutch Vico Therapeutics strengthens leadership team with the appointment of Rupert Sandbrink as Chief Medical Officer an","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}